Your browser is no longer supported. Please, upgrade your browser.
Settings
NVO [NYSE]
Novo Nordisk A/S
Index- P/E37.65 EPS (ttm)1.43 Insider Own- Shs Outstand2.11B Perf Week8.70%
Market Cap113.87B Forward P/E25.53 EPS next Y2.11 Insider Trans- Shs Float1.97B Perf Month15.04%
Income3.79B PEG2.60 EPS next Q- Inst Own9.70% Short Float0.19% Perf Quarter24.86%
Sales12.53B P/S9.09 EPS this Y20.00% Inst Trans4.54% Short Ratio2.52 Perf Half Y14.46%
Book/sh2.06 P/B26.14 EPS next Y21.49% ROA38.70% Target Price75.00 Perf Year21.53%
Cash/sh0.91 P/C59.03 EPS next 5Y14.50% ROE69.00% 52W Range41.07 - 54.38 Perf YTD29.21%
Dividend0.76 P/FCF56.34 EPS past 5Y24.60% ROI56.40% 52W High-0.99% Beta0.90
Dividend %1.41% Quick Ratio1.00 Sales past 5Y12.90% Gross Margin83.70% 52W Low31.08% ATR1.14
Employees40700 Current Ratio1.40 Sales Q/Q8.50% Oper. Margin38.00% RSI (14)79.63 Volatility3.26% 1.84%
OptionableYes Debt/Eq0.01 EPS Q/Q2.90% Profit Margin29.40% Rel Volume4.77 Prev Close53.26
ShortableYes LT Debt/Eq0.00 EarningsApr 30 BMO Payout34.40% Avg Volume1.47M Price53.84
Recom2.00 SMA2013.01% SMA5018.40% SMA20020.22% Volume7,005,825 Change1.09%
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
May-12-09Initiated Piper Jaffray Buy
Apr-24-09Upgrade Citigroup Hold → Buy
Mar-26-09Upgrade UBS Neutral → Buy
Jan-14-09Downgrade Citigroup Hold → Sell
Oct-06-08Upgrade Deutsche Securities Hold → Buy
Aug-29-08Downgrade Bernstein Mkt Perform → Underperform
Aug-21-08Initiated UBS Neutral
Jun-09-08Upgrade HSBC Securities Underweight → Neutral
Feb-26-08Downgrade Bear Stearns Outperform → Peer Perform
Feb-08-08Upgrade Bernstein Mkt Perform → Outperform
Jan-23-08Upgrade Bear Stearns Peer Perform → Outperform
Aug-09-07Downgrade Lehman Brothers Overweight → Equal-weight
Mar-27-15 11:39PM  Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire Jim Simons Holdings for Long-Run at Insider Monkey
11:37PM  Novo Nordisks Insulin Move Is Right Medicine at The Wall Street Journal
06:15PM  Novo Nordisk to Submit Interim DEVOTE Data to the FDA - Analyst Blog
03:10PM  Orexigen's Obesity Drug Mysimba Gains European Approval - Analyst Blog
02:18PM  Insulin: moving the needle at Financial Times
01:15PM  European stocks snap win streak; DAX logs first weekly loss in 2 months at MarketWatch
11:19AM  Sanofi to launch Toujeo diabetes drug in U.S. on Monday -source Reuters
11:06AM  European shares set for 2015's biggest weekly fall despite Novo Nordisk surge Reuters
09:40AM  Novo Nordisk's Insulin Move Is Right Medicine at The Wall Street Journal
08:13AM  Can The Uptrend Continue for Novo Nordisk (NVO)? - Tale of the Tape
07:39AM  Novo Nordisk surge buoys European shares after two-day slide Reuters
07:39AM  March 27 Premarket Briefing: 10 Things You Should Know
07:25AM  Cruise news you can use, plus more Friday business headlines at bizjournals.com
06:10AM  European Stocks Rebound From Two-Day Drop
04:41AM  Novo Nordisk Soars on Plan to Resubmit Rejected Insulin in U.S. at Bloomberg
Mar-26-15 06:49PM  Novo Nordisk's Onset 1 & Onset 2 Meet Primary Objectives - Analyst Blog +6.90%
06:40PM  Sanofi Reveals Cerdelga Data, FDA OK's Quadracel Vaccine - Analyst Blog
06:36PM  Red Hat, Signet Top Buy Points En Route To New Highs at Investor's Business Daily
04:01PM  Novo Nordisk (NVO) Stock Gains Today on Drug Application Resubmission at TheStreet
01:57PM  Novo Nordisk to Refile Tresiba in the U.S. on Interim Analysis at Bloomberg
11:46AM  The Investor's Solution to Low, Low Interest Rates: Part I at Forbes
08:55AM  Merck in $10B Buyback; Keytruda Tops Melanoma Study - Analyst Blog
Mar-24-15 01:40PM  Novo Nordisk's Saxenda Gets EU Approval for Obesity - Analyst Blog
08:47AM  Bristol-Myers in Autoimmune Program Deal at The Wall Street Journal
Mar-19-15 04:10PM  Pfizer Announces Publication of CAPiTA Data on Prevenar 13 - Analyst Blog
10:38AM  Novo Nordisk On Diversity In Diabetes Trials: "We Could Do Better" at Forbes
Mar-18-15 05:10PM  Valeant (VRX) Prices Shares to Finance Salix Acquisition - Analyst Blog
03:38PM  AstraZeneca Presents Encouraging Heart Drug Brilinta Data - Analyst Blog
02:20PM  Novartis' Jakavi Gets EC Approval for Polycythemia Vera - Analyst Blog
10:53AM  Novo Nordisk A/S - Share repurchase programme at noodls
Mar-17-15 12:17AM  Weight-Loss Drugs Seek Acceptance From Patients and Physicians at The Wall Street Journal
Mar-16-15 01:17PM  Weight-Loss Drugs Try Again at The Wall Street Journal
Mar-09-15 05:06PM  Novo Nordisk's Saxenda: New Data from Phase IIIa Study - Analyst Blog
Mar-06-15 03:16AM  Novo Nordisk A/S gennemfører succesfuld børsnotering af NNIT A/S at noodls
Feb-23-15 05:23PM  Novo Nordisk's Oral Semaglutide Positive in Diabetes Study - Analyst Blog
Feb-20-15 11:42AM  Novo Nordisk Pops On Successful Diabetes Drug Trial at Investor's Business Daily +5.28%
Feb-12-15 01:40PM  Baxter Announces Positive Data for BAX 855; Competition Rife - Analyst Blog
Feb-06-15 09:00AM  On MannKind, Diabetics Have One Up On Wall Street at Forbes
Feb-05-15 10:47AM  Novo Nordisk files annual report with the SEC at noodls
Feb-03-15 09:47PM  Sale of Seattle BioMed, Juno building sets Seattle price record at bizjournals.com
07:00AM  Novo-Nordisk As (NVO): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Feb-02-15 09:46AM  Novo Nordisk's Q4 Earnings Rise Y/Y, Provides 2015 Outlook - Analyst Blog Zacks
Jan-30-15 08:59AM  Diabetics: Use Your Firsthand Experience To Beat Wall Street at Forbes
Jan-28-15 06:05AM  Up to Speed: Peltz receives ammo in fight against DuPont (Video) at bizjournals.com
Jan-27-15 03:30PM  Afrezza Breathes Life Into MannKind at Forbes
Jan-26-15 02:03PM  Novo Nordisk stock rises 3% at MarketWatch
01:39PM  4 Stocks Spiking on Unusual Volume: Novo Nordisk and More at TheStreet
Jan-20-15 02:10PM  Novo Nordisk's Xultophy to Launch First in Switzerland - Analyst Blog Zacks
01:41PM  Three Companies That Should Benefit From a Stronger U.S. Dollar at TheStreet
Jan-14-15 04:42PM  CSE Enjoys Record Year in 2014, International Outreach and Trading Initiatives Help Shape Agenda for New Year Marketwired
01:55PM  5 Obesity Stocks Investors Are Watching Benzinga
Jan-13-15 03:22PM  Pharma Grows Itself a New Challenge -- Overheard at The Wall Street Journal
Jan-05-15 12:18AM  Overheard: Novo Nordisks Weighty Issue at The Wall Street Journal
Jan-04-15 02:31PM  [$$] Overheard: Novo Nordisk's Weighty Issue at The Wall Street Journal
11:32AM  Novo Nordisk Shapes Up for New Year at The Wall Street Journal
Jan-02-15 08:40AM  Novo Nordisk A/S - Status regarding Novo Nordisk's holding of its own shares Globe Newswire Europe
Dec-30-14 09:43AM  Eminence Capital raises position in CBS Outdoor Americas Inc. Market Realist
Dec-26-14 12:35PM  4 Potential Blockbuster Drugs The FDA Just Approved at Investor's Business Daily
Dec-24-14 09:31AM  Stocks to Watch: American Realty, Brink's, Novo Nordisk, TECO at The Wall Street Journal
09:23AM  Cramer's Mad Dash: Pharma movers CNBC
Dec-08-14 04:54PM  How To Profit From The Obesity Epidemic Benzinga
Dec-05-14 05:39PM  Paralegal: Sanofi fired her for whistleblowing AP
Dec-04-14 12:13PM  A Look At 4 ETFs From The 4 'Least Corrupt' Countries Benzinga
Dec-01-14 10:09AM  Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013 PR Newswire
Nov-26-14 06:55AM  [$$] Novo Could Put Money Where Its Mouth Is at The Wall Street Journal
Nov-24-14 05:15PM  Novo Nordisk's Victoza Recommended for Label Expansion Zacks
07:00AM  Sanofi Shakes Off Patent Losses Morningstar
Nov-20-14 11:44AM  Sanofi's Bullish Pipeline Forecast Underwhelms Street at Investor's Business Daily
Nov-04-14 05:43PM  Media Release - Top 100 Employer CNW Group
Nov-03-14 10:10AM  Novo Nordisk's Earnings Rise in Q3, 2014 Outlook Narrowed Zacks
Oct-31-14 03:07AM  Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% Zacks
Oct-30-14 05:21PM  Market Thorns, Roses, All Time Highs, and ETF All Time Highs... Yahoo Finance Blogs +6.21%
02:35PM  Sanofi Beats on Q3 Earnings but Lantus Outlook Disappoints Zacks
01:10PM  Alcatel-Lucent rallies, Lufthansa slides: Europes big stock movers at MarketWatch
01:02PM  European stocks climb for third straight day at MarketWatch
05:32AM  [$$] Novo Nordisk Reassures Investors at The Wall Street Journal
Oct-29-14 12:51PM  Sanofi Axes CEO, Hit By Multiple Downgrades at Investor's Business Daily
10:16AM  Sanofi fires CEO CNBC
Oct-28-14 08:17PM  Low Drug Sales Drag Down Shares of Sanofi and Gilead at New York Times -5.01%
05:58PM  Market Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
02:42PM  French Drugmaker Sanofi Warns Of Tougher Competition at Investor's Business Daily
12:37PM  Sanofi Diabetes Outlook Signals an 'Undisciplined' Price War may Erupt at The Wall Street Journal
12:29PM  Good gains as European markets close CNBC
09:33AM  Sanofi Stuns Investors as U.S. Price Pressure Bites at The Wall Street Journal
08:39AM  Pharmalot, Pharmalittle: We're Reading About Sanofi, Lilly and Lots More!! at The Wall Street Journal
Oct-25-14 01:26AM  [$$] The Perils of One-Country Funds at Barrons.com
Oct-23-14 03:30PM  Eli Lilly/Boehringer's Diabetes Drug Under FDA Review Zacks
Oct-16-14 07:59AM  Media Advisory - Dare to Tell the Truth About Vaginal Atrophy (VA) PR Newswire
Oct-07-14 06:08PM  Actavis, Jazz, Novo Lead Top World Stocks List at Investor's Business Daily
Oct-01-14 02:39PM  3 Companies Helping To Keep Diabetes Rates Lower Benzinga
Sep-29-14 01:03PM  Today's Stocks Driving Success For The Drugs Industry at TheStreet
Sep-25-14 09:08PM  Interim for Novo Resources Corp. Company Spotlight
Sep-22-14 05:20PM  Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes Zacks
Sep-18-14 06:53PM  Five Leading International Stocks Near Buy Points at Investor's Business Daily
05:24PM  Today's Market Thorns, Roses and All Time Highs... Yahoo Finance Blogs
04:52PM  FDA Approves Lilly's Once-Weekly Shot For Diabetes at Forbes
07:59AM  Novo Nordisk Marks 90 Years of Innovating Diabetes Care PR Newswire
Sep-17-14 05:12PM  The Market's Thorns, Roses, and All Time Highs... Yahoo Finance Blogs
05:10PM  Novo Nordisk's Tresiba Effective in Children & Adolescents Zacks
Sep-12-14 04:10PM  Novo Nordisk's Saxenda Gets Positive Opinion for Obesity Zacks
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.